Although the results of the two cell lines in our study were quantitatively slightly different (possibly due to the incomplete knockdown of B2M by RNAi), the similar effects suggested that B2M is essential for MSCs to trigger EMT by enhancing mobility and acquisition of stem-like properties in ESCC cells in vitro and in vivo. The gene discussed is B2M; the disease is esophageal squamous cell carcinoma.